Heterochromatin at pericentric domains represents a paradigm for understanding how a functional nuclear domain is established and maintained. Studies in Schizosaccharomyces pombe and Drosophila have advanced our knowledge concerning basic mechanisms and conserved components in the organization of the domain 1 . In particular, HP1 proteins that accumulate in these domains are highly conserved from S. pombe to mammals. However, in mammalian cells, how HP1 is specifically targeted de novo to initiate formation of a domain of accumulation as found in pericentric heterochromatin 2,3 remains mysterious. The recognition of H3K9me3 by HP1 (refs. 4, 5) , which exemplifies the paradigm of the reader model in the histone code hypothesis 6,7 , does not necessarily provide on its own a de novo specific targeting mechanism. One should also consider other HP1 binding partners 8, 9 , potential post-translational modifications 10 and the elusive RNA that has been linked to the presence of HP1 at pericentric heterochromatin 11,12 . Although transcripts from major satellite DNA repeats have been identified 13, 14 , a functional connection between specific RNAs and HP1 has not yet been established. Taken together, these data prompted us to explore further the HP1-RNA connection and particular post-translational modifications or partners that could provide a means for the de novo targeting of HP1 to pericentric heterochromatin, thereby helping to define this specific subnuclear compartment.
A r t i c l e s
Heterochromatin at pericentric domains represents a paradigm for understanding how a functional nuclear domain is established and maintained. Studies in Schizosaccharomyces pombe and Drosophila have advanced our knowledge concerning basic mechanisms and conserved components in the organization of the domain 1 . In particular, HP1 proteins that accumulate in these domains are highly conserved from S. pombe to mammals. However, in mammalian cells, how HP1 is specifically targeted de novo to initiate formation of a domain of accumulation as found in pericentric heterochromatin 2, 3 remains mysterious. The recognition of H3K9me3 by HP1 (refs. 4,5) , which exemplifies the paradigm of the reader model in the histone code hypothesis 6, 7 , does not necessarily provide on its own a de novo specific targeting mechanism. One should also consider other HP1 binding partners 8, 9 , potential post-translational modifications 10 and the elusive RNA that has been linked to the presence of HP1 at pericentric heterochromatin 11, 12 . Although transcripts from major satellite DNA repeats have been identified 13, 14 , a functional connection between specific RNAs and HP1 has not yet been established. Taken together, these data prompted us to explore further the HP1-RNA connection and particular post-translational modifications or partners that could provide a means for the de novo targeting of HP1 to pericentric heterochromatin, thereby helping to define this specific subnuclear compartment.
RESULTS

SUMO-1-HP1a interacts with forward major RNA
We first verified that repetitive DNA sequences in mouse centromeres, known as major and minor satellites in pericentric and centric heterochromatin, respectively 15 , can be transcribed in both orientations. All the transcripts detected by RT-PCR analysis with strand-specific primers for major or minor satellites had various sizes corresponding to multiple repeats of their basic units (Fig. 1a) . We next examined whether some of these transcripts could be stably found in the nucleus. As a reference for comparison, we used the well-defined organization of chromocenters with major satellite repeats surrounded by minor satellite DNA (Fig. 1b , left, DNA fluorescence in situ hybridization (FISH)) 2 . For this, we exploited fluorescently labeled locked nucleic acid (LNA) probes for RNA FISH that specifically detect major and minor transcripts in either forward or reverse orientation. Whereas minor RNAs were barely detectable, LNA probes for major RNAs in both orientations revealed a substantial number of nuclear spots frequently associated with or close to chromocenters (Fig. 1b, middle) . These signals were not a result of DNA cross-hybridization, as they were undetectable after RNase treatment (Supplementary Fig. 1 ). With some variations from cell to cell suggesting cell cycle modulation, reverse major RNAs were usually detected as fewer and larger spots (Fig. 1b , middle, red), and forward major RNA signals were smaller in size and present in higher numbers (Fig. 1b, green) . Notably, these forward major RNAs were consistently at the periphery of HP1α domains (Fig. 1b , right, immuno-RNA FISH and Supplementary  Fig. 2a ). Because active transcription occurs frequently in the external part of chromosomal domains by DNA looping out 16 , they may represent primary transcripts stably maintained at the site of transcription. Notably, HP1α accumulated at major satellite domains, away from minor satellites, which were juxtaposed ( Fig. 1c HP1 enrichment at pericentric heterochromatin is considered important for centromere function. Although HP1 binding to H3K9me3 can explain its accumulation at pericentric heterochromatin, how it is initially targeted there remains unclear. Here, in mouse cells, we reveal the presence of long nuclear noncoding transcripts corresponding to major satellite repeats at the periphery of pericentric heterochromatin. Furthermore, we find that major transcripts in the forward orientation specifically associate with SUMO-modified HP1 proteins. We identified this modification as SUMO-1 and mapped it in the hinge domain of HP1a. Notably, the hinge domain and its SUMOylation proved critical to promote the initial targeting of HP1a to pericentric domains using de novo localization assays, whereas they are dispensable for maintenance of HP1 domains. We propose that SUMO-HP1, through a specific association with major forward transcript, is guided at the pericentric heterochromatin domain to seed further HP1 localization. Fig. 2b and Supplementary Fig. 3a) . Mass spectrometry analysis of the RNA-associated proteins identified mainly heterogeneous nuclear ribonucleoproteins (hnRNPs) and proteins involved in RNA processing ( Supplementary Fig. 3b and Supplementary  Table 1 ) including vigilin, RNA helicase A (RHA) and Ras-GAP SH3 domain-binding protein (G3bp), which were all validated by protein blotting (Fig. 2c) . Vigilin and the Drosophila RHA ortholog, maleless (MLE), are thought to play roles in heterochromatin formation and X-chromosome dosage compensation, respectively 18, 19 , whereas G3bp may be involved in RNA metabolism 20 . Notably, under these experimental conditions, we did not detect any significant association between HP1α and major or minor RNAs either by mass spectrometry (Supplementary Fig. 3b ) or protein blotting (Fig. 2c) . Given our in vitro observations (Fig. 2a) , we wondered whether posttranslational modification of HP1α could promote in vivo HP1α binding to RNA. Indeed, HP1 can be phosphorylated 10 , and in fission yeast, Swi6 (HP1) is SUMOylated in vivo 21 . Furthermore, defective SUMOylation of Swi6 results in a substantial reduction in heterochromatin stability. This prompted us to repeat our RNA pull-down strategy with nuclear extracts prepared in the presence of a cocktail of phosphatase inhibitors and N-ethylmaleimide (NEM), a strong inhibitor of SUMO isopeptidases 22 . Remarkably, protein blotting with an HP1α antibody revealed a slower migrating band in the input for HP1α that was not detected in the absence of NEM and that was then specifically enriched in precipitates with forward major RNAs corresponding to either one or two satellite repeats length A r t i c l e s ( Fig. 2d ; Maj1 F or Maj2 F). This band, with an approximate additional molecular mass of ~11 kDa compared to HP1α, might represent a ubiquitin or a SUMO moiety. We confirmed that this slower-migrating form was modified by SUMO-1 but not SUMO-2/3, using specific antibodies (Fig. 2d) . We obtained similar results with antibodies specific to HP1β and HP1γ ( Supplementary  Fig. 3c ), indicating that all HP1 isoforms can potentially be SUMOylated in vivo and are specifically retrieved with forward major RNAs. Although the forward major RNA pulls down SUMO-1-HP1α, we estimated that only a small percentage of HP1α was SUMO-1 modified in vivo (less than 1% of the total protein from nuclear extracts; Fig. 2d ). This low representation is in agreement with rapid cycles of SUMOylation and deSUMOylation, as reported for other proteins weakly detected in a SUMO-modified state in vivo 23, 24 .
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The hinge domain of HP1a is a major target for SUMOylation
To confirm independently that HP1α is SUMOylated in vivo, we co-transfected HA-tagged HP1α (e-HP1α) and GFP-SUMO-1 into NIH 3T3 cells to prepare total cell extracts and carried out immunoprecipitations with anti-HA beads under conditions that preserved the SUMO modification 25 . Protein blot analysis using GFP antibodies clearly revealed a band corresponding to GFP-SUMO-e-HP1α ( Supplementary Fig. 4a ), demonstrating unambiguously that HP1α can be SUMOylated in vivo. To determine which region of HP1α was modified by SUMO, we next used an in vitro SUMOylation assay with either wild-type (W) or mutant (M) SUMO-1 protein in the presence of E1-activating and E2-conjugating (Ubc9) SUMO enzymes and various GST-HP1α domains (Fig. 3a) . Protein blot analysis using GST antibodies showed SUMO modification on the full-length HP1α, the chromo-hinge, the hinge-chromoshadow and the hinge domains, with the latter domain showing the highest level of SUMOylation ( Fig. 3b and Supplementary Fig. 4b , asterisks). This is also true when using SUMO-2 or SUMO-3 ( Supplementary   Fig. 4c ). These results revealed that the hinge, the same domain of HP1α that displayed RNA-binding activity ( Fig. 2a) , is a target for SUMOylation. Because the fusion of Ubc9 to a substrate provides a convenient way to increase its SUMOylation 26 , we also verified with a GST-HP1α-Ubc9 fusion protein that we could enhance SUMO-1 modification of HP1α in vitro without adding the E2 enzyme ( Fig. 3c) . Then, using the GST-HP1α hinge and SUMO-1 proteins as above ( Supplementary Fig. 5a ), we further identified specific SUMOylated residues on HP1α by mass spectrometry. In the hinge domain, among the 13 lysines that are potential targets for SUMOylation, we found that Lys84 of HP1α in the peptide EKSEGNK (with the underlined K indicating Lys84) was unequivocally identified as SUMOylated by mass (with high accuracy in the Orbitrap; Fig. 3d , right spectra, arrow) and sequence (by tandem mass spectrometry (MS/MS) in the QSTAR mass spectrometer; Fig. 3d ; the y and b ions are shown). However, we also found other potentially SUMOylated lysines in HP1α (for example, KMoxK, SKK, KYK or YKK; Supplementary Fig. 5b,c) , indicating alternative usage of various lysine residues. We thus mutated successively each of the individual 13 lysines to arginines and performed in vitro SUMOylation assays as above and in vivo co-transfections as in Supplementary Figure 4a . We observed in all cases that once we mutated one residue, an alternative SUMOylation site was used (data not shown), showing the usage of more than one SUMOylation site and corroborating our mass spectrometry data. This suggests a lack of a strict requirement for a 'specific' SUMO-modified residue.
SUMOylation of HP1a promotes its targeting
Because the fusion of Ubc9 to HP1α increases SUMOylation efficiency in vitro (Fig. 3c) , we thus generated an HP1α-Ubc9-HA fusion construct (e-HP1α-Ubc9) for in vivo expression and further analysis in a cellular context. Transfection of e-HP1α-Ubc9 or e-HP1α into NIH 3T3 cells lead to comparable levels of proteins being expressed ( Supplementary Fig. 6a,b; anti-HA). Notably, we detected a higher amount of SUMO-modified e-HP1α-Ubc9. In total cell extracts, we found that e-HP1α-Ubc9 was mainly SUMO-2/3 modified, reflecting the readily available endogenous SUMO-2 and SUMO-3 proteins compared to the limited amount of free endogenous SUMO-1 protein in cells (compare SUMO-1 with SUMO-2/3 inputs in Fig. 2d ) 23 . This could be compensated for by providing exogenous SUMO-1 by transient transfection (Supplementary Fig. 6c ). These in vivo results underline the fact that HP1α can be modified by SUMO-1, SUMO-2 or SUMO-3 depending on the available substrate, as shown in vitro (Fig. 3b,c and Supplementary Fig. 4b,c) . We verified that the catalytic activity of the fused Ubc9 was directly involved in HP1α SUMOylation enhancement using a Ubc9 catalytic mutant fused to HP1α (e-HP1α-Ubc9C93S). In comparaison with wild-type (wt) e-HP1α-Ubc9, we detected a strongly reduced SUMOylation of e-HP1α-Ubc9C93S (Supplementary Fig. 6c ).
Next, we examined e-HP1α-Ubc9 and e-HP1α localization in NIH 3T3 cells. Both of them could accumulate at pericentric domains where endogenous HP1α is already located (Fig. 3e) . Thus, under these conditions, promoting HP1 SUMOylation did not give a particular advantage for the recruitment and maintenance of exogenous HP1 to pre-existing HP1 domains of accumulation. Next, we wondered whether HP1α SUMOylation could be required more specifically for a de novo targeting of HP1α to heterochromatin domains. To test this hypothesis, we used mouse embryonic fibroblasts (MEFs) derived from Suv39h double-null mice in which the H3K9me3 mark and HP1α were no longer enriched at pericentric heterochromatin 11, 27 (Fig. 4) . Transfection with exogenous Myc-SUV39H1 could restore the proper localization of these marks (Fig. 4b) 5, 28 . As we postulated that the interaction between major RNAs and SUMOylated HP1α targets HP1α to pericentric domains, we first verified that we could detect major RNAs by RNA-FISH in Suv39h double-null MEFs (Supplementary Fig. 7a ). We then transiently transfected Suv39h double-null cells with e-HP1α or e-HP1α-Ubc9 in the absence of Myc-SUV39H1 and verified that the proteins were expressed at comparable levels (Fig. 4c) . We could not detect the typical localization to chromocenters in cells transfected with e-HP1α (Fig. 4c) . In contrast, in about 10% of cells transfected with e-HP1α-Ubc9, we found a faint but detectable pericentric localization 6 h post transfection. Remarkably, in the latter case, A r t i c l e s we could not detect H3K9me3 accumulation at pericentric heterochromatin ( Fig. 4c and  Supplementary Fig. 7b ), whereas H3K9me1 was clearly visible at these domains in all Suv39h double-null cells (Supplementary Fig. 7c ). Thus, a targeting of e-HP1α-Ubc9 to pericentric heterochromatin could occur in the absence of SUV39H1-dependent H3K9me3. However, whereas e-HP1α-Ubc9 was more efficiently targeted than e-HP1α, the low fraction of cells showing this staining suggested that following this initial recruitment, retention at pericentric domains was rather inefficient. We thus modified our assay to monitor the localization of e-HP1α or e-HP1α-Ubc9 to pericentric chromatin in the presence of Myc-SUV39H1 assuming that H3K9me3 could promote stabilization (Fig. 4d) . Immunofluorescence analysis revealed that e-HP1α, e-HP1α-Ubc9C93S and e-HP1α-Ubc9wt accumulated at pericentric heterochromatin when co-transfected with Myc-SUV39H1, in contrast to a negative control protein, e-hnRNPC (Fig. 4e) . Notably, e-HP1α-Ubc9wt localized to these domains more efficiently than e-HP1α and e-HP1α-Ubc9C93S (62% versus 37% and 39% of positive cells, respectively, 6 h post transfection) for comparable levels of expressed proteins (Supplementary Fig. 8a) . Also, the e-HP1α and e-HP1α-Ubc9C93S overall staining in the nucleus was rather diffuse compared to e-HP1α-Ubc9wt staining, suggesting that a significant fraction of e-HP1α and e-HP1α-Ubc9C93S is not localized at pericentric heterochromatin (see Fig. 4e and Supplementary Fig. 8b and its legend for details). Taken together, these results indicate that enhancing SUMOylation on HP1α promotes a more efficient accumulation at pericentric heterochromatin. We then performed a time-course analysis to compare the appearance of HP1α at pericentric heterochromatin in Suv39h double-null cells co-transfected with Myc-SUV39H1 and e-HP1α or e-HP1α-Ubc9 (Fig. 4f) . We found that e-HP1α-Ubc9 always localized more efficiently to pericentric heterochromatin compared to e-HP1α (52% versus 31% of positive cells, respectively, 4 h post transfection) for comparable levels of expressed proteins along the time-course analysis (Fig. 4f) . The different efficiencies with which these proteins localized to pericentric heterochromatin support the hypothesis of SUMOylation acting as a limiting step to promote HP1α targeting. In support of this hypothesis, although toxic, the direct fusion of SUMO-1 to HP1α showed an even more efficient accumulation compared to e-HP1α-Ubc9 (see Supplementary Fig. 9 and its legend for details). The simplest interpretation for this is that a higher amount of SUMOylated protein provided by HP1α-Ubc9 fusion would allow a rapid targeting to pericentric domains, whereas HP1α alone would be delayed by the time needed to undergo an entire cycle of SUMOylation. Overall, our data underline the importance of the HP1α SUMO modification before HP1α targeting to pericentric heterochromatin. 
A r t i c l e s
The hinge domain is required for de novo localization of HP1α
Given that the hinge domain, which shows RNA-binding properties 12 , is the target for SUMOylation at multiple sites (Fig. 3b) , we generated mutants of e-HP1α and e-HP1α-Ubc9 lacking the hinge domain and assayed whether they could specifically localize de novo to pericentric heterochromatin in Suv39h double-null cells. After transfection of e-HP1α∆H and e-HP1α∆H-Ubc9 constructs in NIH 3T3 cells, we found that the hinge domain was perfectly dispensable to localize HP1α at pre-existing HP1 domains in a 'maintenance assay' (Fig. 5a,b) as reported in Drosophila Kc167 cells 29 . Notably, when using Suv39h double-null cells for our de novo localization assay, after co-transfection with Myc-SUV39H1, the e-HP1α mutant lacking the hinge domain did not localize at pericentric heterochromatin, in contrast to the wild-type protein, which did accumulate at these domains (44% positive cells; Fig. 5c ). We verified that all transfected proteins were expressed at comparable levels (Fig. 5d) . Even when Ubc9 was fused to the mutant protein, we did not detect localization of e-HP1α∆H-Ubc9 at pericentric domains. These data clearly show that the hinge domain, the SUMO modification and the association with major RNAs are critical for de novo localization of HP1α at pericentric heterochromatin.
DISCUSSION
Based on our data, we propose a model for the de novo targeting and local accumulation of HP1α at pericentric heterochromatin by a multistep mechanism involving initial SUMO-dependent targeting as a 'seeding' step (Fig. 6, '1' ). This SUMO modification imposed in the hinge domain of HP1 would leave the chromo and chromoshadow domains available for other interactions with heterochromatin proteins (as represented in Fig. 6 ). Subsequent 'chromatin marking' steps would follow, including SUV39-dependent H3K9me3 to ensure HP1 stabilization (Fig. 6, '2' ) and accumulation through a self-enforcing loop (Fig. 6, '3') 1 . Our identification of a specific association between SUMO1-HP1α and major RNAs in the forward orientation (Fig. 2) provides a molecular basis for the 'seeding' step. Such association may help guide SUMO-HP1α specifically to pericentric heterochromatin. The specificity of the interaction promoted by SUMOylation, either by the sequence, by particular structures formed by these RNAs or by known HP1 partners 9 , remains to be determined. Importantly, the HP1-RNA interaction is specific for the forward strand, which is purine rich and may thus adopt a distinct structure. Furthermore, it will be interesting to examine potential SUMO-binding protein candidates 30 . Following the 'seeding' event, coordination with SUV39-mediated H3K9 methylation would be key for HP1α stabilization. Although this step could formally be independent of SUMOylation, it is possible that SUMO-HP1 and RNA interaction may promote additional interactions with other partners (such as SUV39) and enhance SUV39 enzymatic activity. In this way, the seeding event might favor A r t i c l e s further stabilization steps to establish a robust system for the maintenance of heterochromatin domains. Given that several proteins involved in heterochromatin stability have been shown to bind SUMO conjugates 31 , it is tempting to speculate that they could also bind SUMO-HP1. Future work should address how and where HP1 gets SUMOylated and which enzymes trigger both its SUMOylation and deSUMOylation as well as the impact on centromere function. Given the conserved importance of HP1 from fission yeast to mammals 3, 32 , further investigation of these issues in various organisms should help to define some general principles.
We detected forward RNAs as long species (several repeat lengths) (Fig. 1a) and showed that they localize at the periphery of pericentric domains (Fig. 1b and Supplementary Fig. 2a) ; however, we did not detect small double-stranded RNA corresponding to major satellites as described for the maintenance of heterochromatin in S. pombe 1, 33 . It is notable that even in S. pombe, primal RNAs have been reported to be important for heterochromatin formation 34 . Although we do not exclude an RNAi pathway in connection with heterochromatin in mammalian cells 35, 36 , the fact that we detected long noncoding RNAs that are stably located in the nucleus just at the periphery of major satellite domains is very compelling. This is reminiscent of other long nuclear noncoding RNA, such as the lncRNA HOTAIR, proposed to serve as a modular scaffold for histone modification complexes involved in Polycomb function 37 , or Xist, which is critical to establish the silent state of the inactive X in mammals. Moreover, Xist RNA is known to be critical in setting up a de novo silent domain at specific times during development 38, 39 . In this respect, the situation of early development in mice 40, 41 is particularly interesting because a burst of transcription of major RNAs occurs just before the formation of HP1 domains of accumulation on the paternal genome 42 . Thus, it is tempting to speculate that SUMOylation could be critical also at this time and perhaps during other developmental time windows. This mechanism could apply to certain cell types when major rearrangements of the genome occur as observed during spermatogenesis 43 , differentiation 44, 45 , reprogramming in the mouse germ line 46 , in specialized cell types like Rod photoreceptor cells 47 or even in the formation of senescence-associated heterochromatin foci (SAHF) 48 .
Beyond HP1, the concept that a modification, like SUMO, imposed on a chromatin protein could promote localization guided by a particular transcript in the nucleus should be explored. One may wonder whether similar mechanisms also apply to the formation of other local domains of accumulation or nuclear compartments such as Polycomb or insulator bodies.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
95% and 100% EtOH, we carried out hybridization with 0.4 µM locked nucleic acid (LNA) fluorescent probes (Exiqon) in 50% formamide (Sigma), ×2 SSC (Sigma), 10% dextran sulfate (Fluka), 10 mM VRC (NEB) and 2 mg/mL BSA (NEB) in a humid chamber for 35 min at 37 °C. After three washes in ×0.1 SSC for 5 min at 60 °C, we stained the DNA with DAPI staining and mounted the cells in VECTASHIELD (Vector Laboratories). For immuno-RNA FISH, we performed RNA FISH as described above. After post-hybridization washes, we post-fixed cells in 3% paraformaldehyde in PBS for 12 min and processed them for immunostaining. DNA FISH and immuno-DNA FISH were performed as described 2 , except that here the hybridization mix contained LNA fluorescent probes (0.1 µM), and we performed post-hybridization washes in ×0.1 SSC (three times for 5 min) at 60 °C. The sequences of the LNA fluorescent probes are listed in Supplementary Table 2. RT-PCR analysis. We performed RT-PCR analysis on HP1α-associated RNAs and on total RNA extracted from 3T3 cells with TRIzol (Invitrogen). We digested genomic DNA by incubation with DNase 1 (Sigma). We synthesized first-strand cDNA from 1 µg RNA in 20 µl buffer containing 1 µM forward (For)-or reverse (Rev)-specific primers for major or minor satellites, 0.5 mM dNTPs, 40 U/µl RNasin and 10 U/µl of SuperScript II reverse transcriptase (QIAGEN). We then amplified the generated cDNA by PCR using 1/2,000 and 1/250 dilutions of major and minor cDNA, respectively, and a PCR Master Kit (Roche) supplemented with 0.5 µM specific primers during 45 cycles. Primer sequences are listed in Supplementary Table 2.
Chromatin immunoprecipitation (ChIP). We extracted NIH 3T3 cells with Triton X-100 to remove soluble proteins as previously described 52 and crosslinked them with 1.5% formaldehyde in PBS for 20 min at room temperature. We then added 125 mM glycine for 20 min to quench any residual formaldehyde. After one wash with PBS, we collected the cells by scraping and resuspended them in ChIP buffer (20 mM Tris-HCl at pH 7.5, 200 mM NaCl, 0.2% Nonidet P-40, 1% gelatin and 80 U RNasin). We then sonicated the cells seven times for 30 s on high intensity (Bioruptor sonicator, CosmoBio Inc.) and centrifuged them at 10,000g for 5 min. We incubated approximately 200-300 µg of supernatant containing the soluble chromatin with 20 µl of sera against HP1α raised in the laboratory for 3 h at 4 °C. We used pre-immune sera as the negative control. Then we added 100 µl of Protein-A sepharose slurry (50% wt/vol, Amersham Biosciences) and incubated for 3 h at 4 °C on a rotating wheel. We recovered the immunoprecipitated chromatin by centrifugation, washed it five times with 1 ml of ChIP buffer and resuspended it in 10 mM Tris-HCl at pH 7.5, 1 mM EDTA and 0.2% SDS. We reversed the cross-link by incubation at 65 °C overnight. We then extracted the HP1α-associated RNAs with TRIzol (Invitrogen), and we performed RT-PCR analysis.
In vitro SUMOylation assays. We produced recombinant proteins in Escherichia coli by expressing constructs corresponding to the GST-HP1α full-length protein and fragments thereof and GST-HP1α-Ubc9. We used the recombinant proteins in in vitro SUMOylation reactions using the SUMOlink kits (Active Motif) according to the manufacturer's instructions. We validated SUMOylation of HP1α and HP1α-Ubc9 by protein blot with GST antibodies. For analysis of the SUMOylated GST-HP1α hinge fragment by mass spectrometry, we used a total of 5 µg of GST-HP1α hinge and 10 µg of SUMO-1 protein. We ran 90% of the reaction mixture on a 4-12% Bis-Tris NuPAGE gel (Invitrogen) and stained the gel overnight with LabSafe GEL Blue stain (Biosciences) for later mass spectrometry analysis. We used the remaining 10% of the SUMOylation mixture for protein blotting with rabbit GST and rabbit SUMO-1 (Active Motif; 1:4,000 dilution) antibodies.
Mass spectrometry. We reduced, alkylated and trypsin digested slices (1 mm wide) cut from Coomassie blue-stained gels as previously described 53 . We dried extracted peptides and resolubilized them in solvent A (95/5 water/acetonitrile and 0.1% formic acid) before liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. We concentrated and separated them on an LC Packings system (Dionex S.A.) coupled to the nano-electrospray II ionization interface of a QSTAR Pulsar i (Applied Biosystems/MDS Sciex). HPLC mobile phases contained solvent A and solvent B (20/80 water/acetonitrile and 0.085% formic acid). We eluted bound peptides with a gradient of 5-50% of solvent B. We used information-dependent acquisition (IDA) to acquire MS/MS data, with experiments designed such that the two most abundant peptides were subject to collision-induced dissociation. We twice analyzed the data from the IDA experiments by using MASCOT software (Matrix Science) on an internal server, first without taxonomic restriction to reveal the presence of proteins of interest and mammalian contaminants, then again with the NCBI "Mus musculus" (mouse) database (National Library of Medicine, Bethesda, Maryland, USA, 2005 May 02; 2,452,561 total proteins entries and 41,362 M. musculus proteins entries). We converted the RAW files to the Mascot Generic Format (MGF) and submitted them to the Mascot search engine (version 1.0). We used the following parameters in the database search: full trypsin enzyme specificity; missed cleavages allowed = 1; peptide mass tolerance = 0.8 Da; fragment ion tolerance = 1 Da; monoisotopic molecular weight for both peptide and fragment ion masses; b/y ion search; and fixed carbamidomethyl cysteine modification. We manually validated all data using myProMS 54 .
For SUMO-1 LC-MS/MS experiments, we used two different mass spectrometry platforms in parallel. We achieved peptide concentration and separation using an actively split capillary HPLC system (Ultimate 3000, Dionex) connected to each mass spectrometry platform. The first platform was a quadrupole time-of-flight (Q-TOF) mass spectrometer (QSTAR Elite, Applied Biosystems/MDS Sciex). We acquired a TOF-MS survey scan for 1 s over a mass range of 800-1,200 mass-to-charge ratio (m/z). We used an IDA method to acquire product ion scans on the three most intense 3+ ions per cycle over a mass range of 65-2,000 m/z excluding previously gated ions for 60 s. We used a Smart setting of 2.0. The second platform was an LTQ-Orbitrap XL mass spectrometer (Thermo Fisher Scientific) equipped with a nanospray source using a Pico-Tip (10 µm internal diameter (i.d.), New Objectives). We set the spray voltage to 2.2 kV and the temperature of the heated capillary to 200 °C. The mass spectrometer was operated in data-dependent mode to automatically acquire mass spectrometry and MS/MS spectra. We acquired full scan survey spectra (m/z 615-1,200) in the Orbitrap with a resolution of 100,000 at m/z 400 after accumulation of 1,000,000 charges. We sequentially isolated the five most intense ions and fragmented them in the linear ion trap by collisioninduced dissociation after accumulation of 30,000 ions (normalized collision energy of 35%). Maximum inject times were 500 ms for full scans and 200 ms for MS/MS scans. Dynamic exclusion was enabled with an exclusion duration of 120 s. We calculated and used the monoisotopic m/z values for SUMO-1-GST-HP1α hinge-branched precursor peptides as described 55 to search for the corresponding ions (assignment was confirmed by manually interpreting all MS/MS spectra). We manually validated all reported MS/MS spectra. We considered only branched peptides having an extensive coverage of b and/or y ions. It was assumed that modified (SUMOylated) lysines cannot be cleaved by trypsin, and one trypsin missed cleavage was allowed.
